Insights

  • Date

  • Content Type

  • Reset

Blog

Pregnant women and vaccines against emerging epidemic threats

5.02.19

By Michael Pfleiderer

Vaccines have one of the highest live saving potentials amongst all medicinal products licensed around the globe. One...

Read More

Blog

Drug repurposing: how to protect your asset by an integrated regulatory strategy

23.01.19

By Michael Firgens

Drug repurposing is an alternative cost-effective approach to drug development which builds on already approved drugs and compounds....

Read More

Blog

Cell and gene therapies are changing the face of modern medicine – But how to find the right dose?

14.12.18

By Diane Seimetz

Finding the right dose for the first in human study can be a challenging undertaking for biopharmaceuticals....

Read More

Blog

Cutting costs for cutting edge therapeutic products: ATMP process optimization

4.12.18

By Elena Meurer

The affordability of ATMPs for the health care system and patients lies among the important aspects that...

Read More

Blog

Four important considerations for the successful development of an in vitro or companion diagnostic test

21.11.18

By Linsey Reavie

In vitro diagnostic (IVD) and companion diagnostic (CDx) tests are crucial for the rapid diagnosis, response and...

Read More

Blog

Lost in translation? – How you can smoothly progress to clinical development and beyond

30.10.18

By Dr. Diane Seimetz

For a smooth transition to clinical development stage, careful and intertwined upfront planning across important drug development...

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more